Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome.
Cattaneo D, Ruggenenti P, Baldelli S, Motterlini N, Gotti E, Sandrini S, Salvadori M, Segoloni G, Rigotti P, Donati D, Perico N, Remuzzi G; Mycophenolate Steroids Sparing (MYSS) Genetics Study Group. Cattaneo D, et al. Among authors: donati d. J Am Soc Nephrol. 2009 Jun;20(6):1404-15. doi: 10.1681/ASN.2008080819. Epub 2009 May 21. J Am Soc Nephrol. 2009. PMID: 19470683 Free PMC article.
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
Gotti E, Perico N, Gaspari F, Cattaneo D, Lesti MD, Ruggenenti P, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Federico S, Sparacino V, Mourad G, Bosmans JL, Dimitrov BD, Iordache BE, Remuzzi G. Gotti E, et al. Among authors: donati d. Transplant Proc. 2005 Jun;37(5):2037-40. doi: 10.1016/j.transproceed.2005.03.096. Transplant Proc. 2005. PMID: 15964332 Clinical Trial.
A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.
Montagnino G, Sandrini S, Casciani C, Schena FP, Carmellini M, Civati G, Rigotti P, Cossu M, Altieri P, Salvadori M, Federico S, Stefoni S, Cambi V, Albertazzi A, Buoncristiani U, Berloco P, Segoloni G, Boschiero L, Sparacino V, Donati D, Turello E, Dal Canton A, Ponticelli C. Montagnino G, et al. Among authors: donati d. Transplant Proc. 2005 Mar;37(2):788-90. doi: 10.1016/j.transproceed.2004.11.033. Transplant Proc. 2005. PMID: 15848532 Clinical Trial.
Study of lymphocyte costimulatory molecules in renal transplantation.
Biancone L, Donati D, Segoloni G, Turello E, Squiccimarro G, Bussolati B, Cantaluppi V, Amann F, Gastaldi L, Piccoli G, Camussi G. Biancone L, et al. Among authors: donati d. Transplant Proc. 1998 Aug;30(5):2384-6. doi: 10.1016/s0041-1345(98)00662-9. Transplant Proc. 1998. PMID: 9723512 No abstract available.
Interleukin-1 receptors and receptor antagonist in haemodialysis.
Donati D, Degiannis D, Mazzola E, Gastaldi L, Raskova J, Raska K Jr, Camussi G. Donati D, et al. Nephrol Dial Transplant. 1997 Jan;12(1):111-8. doi: 10.1093/ndt/12.1.111. Nephrol Dial Transplant. 1997. PMID: 9027784 Clinical Trial.
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study.
Vitko S, Wlodarczyk Z, Kyllönen L, Czajkowski Z, Margreiter R, Backman L, Perner F, Rigotti P, Jaques B, Abramowicz D, Kessler M, Sanchez-Plumed J, Rostaing L, Rodger RS, Donati D, Vanrenterghem Y. Vitko S, et al. Among authors: donati d. Am J Transplant. 2006 Mar;6(3):531-8. doi: 10.1111/j.1600-6143.2005.01193.x. Am J Transplant. 2006. PMID: 16468962 Free article. Clinical Trial.
638 results